Found: 36
Select item for more details and to access through your institution.
Validation of a multivariable prediction model for post‐engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
- Published in:
- Mycoses, 2019, v. 62, n. 5, p. 418, doi. 10.1111/myc.12891
- By:
- Publication type:
- Article
Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 3, p. 227, doi. 10.1007/s40261-019-00881-7
- By:
- Publication type:
- Article
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 5, p. 724, doi. 10.1111/ejh.13604
- By:
- Publication type:
- Article
Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
- Published in:
- Journal of Clinical Apheresis, 2021, v. 36, n. 4, p. 612, doi. 10.1002/jca.21901
- By:
- Publication type:
- Article
AML-331: Real-Life Evidence of Treatment with Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S306, doi. 10.1016/S2152-2650(21)01727-4
- By:
- Publication type:
- Article
AML-266: Azacitidine or Decitabine Monotherapy for the Treatment of AML: A Comparative Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S296, doi. 10.1016/S2152-2650(21)01706-7
- By:
- Publication type:
- Article
Poster: AML-331: Real-Life Evidence of Treatment with Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S215, doi. 10.1016/S2152-2650(21)01349-5
- By:
- Publication type:
- Article
Poster: AML-266: Azacitidine or Decitabine Monotherapy for the Treatment of AML: A Comparative Systematic Review and Meta-Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S214, doi. 10.1016/S2152-2650(21)01348-3
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054458
- By:
- Publication type:
- Article
A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 12, p. 2003, doi. 10.1002/cncr.33403
- By:
- Publication type:
- Article
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1239, doi. 10.1111/bjh.18815
- By:
- Publication type:
- Article
Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. 672, doi. 10.1111/bjh.16432
- By:
- Publication type:
- Article
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 410, doi. 10.1002/cncr.26273
- By:
- Publication type:
- Article
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2267, doi. 10.3390/cancers15082267
- By:
- Publication type:
- Article
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 438, doi. 10.3390/cancers15020438
- By:
- Publication type:
- Article
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3 -ITD Mutation-Positive Acute Myeloid Leukemia.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2817, doi. 10.3390/cancers14112817
- By:
- Publication type:
- Article
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092342
- By:
- Publication type:
- Article
Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1921, doi. 10.3390/cancers14081921
- By:
- Publication type:
- Article
Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5677, doi. 10.3390/cancers13225677
- By:
- Publication type:
- Article
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2458, doi. 10.3390/cancers13102458
- By:
- Publication type:
- Article
PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1313, doi. 10.3390/cancers12051313
- By:
- Publication type:
- Article
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 451, doi. 10.1007/s00277-023-05582-y
- By:
- Publication type:
- Article
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 9, p. 1989, doi. 10.1007/s00277-020-04186-0
- By:
- Publication type:
- Article
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 2, p. 299, doi. 10.1007/s00277-013-1872-4
- By:
- Publication type:
- Article
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 43, doi. 10.1007/s00277-013-1914-y
- By:
- Publication type:
- Article
Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 12, p. 1845, doi. 10.1007/s00277-012-1596-x
- By:
- Publication type:
- Article
Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 1, p. 19, doi. 10.1007/s00277-011-1331-z
- By:
- Publication type:
- Article
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040878
- By:
- Publication type:
- Article